Abstract
Our previous work demonstrates that DHX32 is upregulated in colorectal cancer (CRC) compared to its adjacent normal tissues. However, how overexpressed DHX32 contributes to CRC remains largely unknown. In this study, we reported that DHX32 was overexpressed in human colon cancer cells. Overexpressed DHX32 promoted SW480 cancer cells proliferation, migration, and invasion, as well as decreased the susceptibility to chemotherapy agent 5-Fluorouracil. Furthermore, PCR array analyses revealed that depleting DHX32 in SW480 colon cancer cells suppressed expression of WISP1, MMP7 and VEGFA in the Wnt pathway, and anti-apoptotic gene BCL2 and CA9, however, elevated expression of pro-apoptotic gene ACSL5. The findings suggested that overexpressed DHX32 played an important role in CRC progression and metastasis and that DHX32 has the potential to serve as a biomarker and a novel therapeutic target for CRC.
References
Jul 20, 1999·Molecular and Cellular Biology·H EndohS Kato
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S GiacchettiF Lévi
Apr 25, 2001·The Journal of Biological Chemistry·T M LewinR A Coleman
Dec 26, 2001·Oncogene·M CausevicF V Fuller-Pace
Aug 7, 2002·Leukemia Research·Mohamed Abdelhaleem
Jan 16, 2003·Oncogene·Kari L Rossow, Ralf Janknecht
Feb 20, 2003·Oncogene·Brian P SchlegelJeffrey D Parvin
Jun 5, 2003·Genomics·Mohamed AbdelhaleemHester Wain
Feb 11, 2004·The Journal of Biological Chemistry·Xiaoling Zhong, Ahmad R Safa
Jul 9, 2004·Biochimica Et Biophysica Acta·Mohamed Abdelhaleem
Sep 3, 2004·Cancer Research·Naomi RobertsonAdrian L Harris
Sep 25, 2004·The Prostate·T OhigashiM Murai
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pia AlhopuroDiego Arango
Aug 29, 2006·Nucleic Acids Research·Frances V Fuller-Pace
Jan 24, 2007·Experimental and Molecular Pathology·Zaman AlliMohamed Abdelhaleem
Aug 8, 2007·Gastroenterology·Nikolaus GasslerJürgen Kopitz
Nov 17, 2007·BMC Genomics·Brian J Wilson, Vincent Giguère
Jan 24, 2009·Journal of Experimental & Clinical Cancer Research : CR·Chunling HuangZhongying Zhang
Apr 30, 2009·British Journal of Cancer·T NodaM Monden
Jun 4, 2010·The Journal of Pharmacology and Experimental Therapeutics·Fabio CianchiLuca Puccetti
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Mar 1, 2012·Current Pharmaceutical Design·Jiujie CuiKeping Xie
May 3, 2012·Molecular Pharmacology·You-Jin KangSang Kook Lee
Apr 9, 2013·Oncogene·D LiR Bals
Apr 16, 2013·Oncogene·H LinH-R Wang
May 10, 2013·Wiley Interdisciplinary Reviews. RNA·Francis Robert, Jerry Pelletier
Oct 15, 2013·British Journal of Pharmacology·M J RoyG Lessene
Nov 6, 2013·Journal of Translational Medicine·Birdal BilirCarlos S Moreno
Citations
Jan 27, 2017·Journal of the National Cancer Institute·Wanpei CaiAlan Prem Kumar
Mar 30, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ailian Zhang, Jincheng Li
Jan 18, 2019·Journal of Translational Medicine·Yi LiuXueqiong Zhu
Mar 31, 2017·Oncology Letters·Meng WangXixiong Kang
Jul 3, 2017·Pathology Oncology Research : POR·Yang ChengJianjie Chen
Mar 18, 2021·Annals of Medicine·Xiaoyun HuJinzhang Chen
Mar 24, 2021·Technology in Cancer Research & Treatment·Bei LiTingbao Zhao
Jun 26, 2021·Nutrition and Cancer·Kinjal P BhadreshaRakesh M Rawal